Why the study?
Does cardiac function influence the diuretic and hemodynamic effects of piretanide in patients with congestive heart failure?
Does cardiac function influence the diuretic and hemodynamic effects of piretanide in patients with congestive heart failure?
In patients with congestive heart failure, the diuretic and hemodynamic responses to piretanide are strongly dependent on baseline cardiac index and resulting diuresis.
May inform piretanide use by baseline cardiac index in heart failure; hypothesis-generating and should not yet change practice.
The influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide was investigated in nine patients with congestive heart failure. The diuretic response to piretanide correlated significantly with the pretreatment cardiac index (r = 0.90). Furthermore, a significant correlation was found between the pretreatment fractional sodium excretion and the cardiac index (r = 0.85). The fractional sodium excretion is reciprocal to the renal sodium and water reabsorption. No change in the hemodynamics was observed prior to the onset of diuresis. At 120 minutes after administration of piretanide, the reduction of mean pulmonary capillary wedge pressure (r = 0.88) and mean right atrial pressure (r = 0.80) was significantly related to the diuretic response. We conclude that the reduced diuretic response to piretanide in patients with low cardiac index is due to increased renal sodium and water reabsorption. The hemodynamic changes following the administration of piretanide are dependent on the diuresis.
No takes yet. Share an insight, caveat, or question.
Hasenfuß et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: